Stifel Financial Corp Cue Biopharma, Inc. Transaction History
Stifel Financial Corp
- $91.8 Billion
- Q1 2025
A detailed history of Stifel Financial Corp transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 203,578 shares of CUE stock, worth $168,969. This represents 0.0% of its overall portfolio holdings.
Number of Shares
203,578
Previous 211,361
3.68%
Holding current value
$168,969
Previous $217,000
14.75%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CUE
# of Institutions
52Shares Held
14.9MCall Options Held
10.1KPut Options Held
1.4K-
Bleichroeder LP New York, NY5MShares$4.15 Million1.56% of portfolio
-
Catalytic Wealth Ria, LLC Cambridge, MA3.33MShares$2.77 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.32MShares$1.92 Million0.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$628,0900.0% of portfolio
-
Geode Capital Management, LLC Boston, MA694KShares$575,9280.0% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $29.4M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...